Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1986 Feb;83(4):1089–1091. doi: 10.1073/pnas.83.4.1089

Elevated erythrocyte adenosine deaminase activity in patients with acquired immunodeficiency syndrome.

M J Cowan, R O Brady, K J Widder
PMCID: PMC323016  PMID: 3006027

Abstract

Acquired immunodeficiency syndrome (AIDS) is an often fatal disease caused by a retrovirus frequently resulting in malignancy and/or opportunistic infection. Because the immune deficiency in AIDS is similar to that in some purine enzyme deficiencies, we measured erythrocyte adenosine deaminase (ADA) and purine nucleoside phosphorylase activities in patients with AIDS, heterosexual controls, and a high-risk asymptomatic population. We found that erythrocyte ADA activity was significantly elevated in patients with AIDS (40 +/- 11 nmol/mg of hemoglobin per hr, mean +/- SD) relative to heterosexual controls (25 +/- 10, P less than 0.001). We also measured ADA activity in a group of individuals at high risk for AIDS and found that approximately half had significantly elevated ADA activities (45 +/- 4, P less than 0.002) that correlated with the presence of antibody to the lymphadenopathy retrovirus. Purine nucleoside phosphorylase activity was relatively normal in patients with AIDS as well as in individuals at risk for AIDS. Increased ADA appears to be a diagnostic marker of AIDS and may be useful in conjunction with antibody to the AIDS-related retrovirus in detecting the presence of infection in asymptomatic high-risk individuals. These data also suggest that, in addition to the lymphocyte, the erythroid cell line may also be infected by the AIDS-related retrovirus.

Full text

PDF
1089

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ammann A. J., Abrams D., Conant M., Chudwin D., Cowan M., Volberding P., Lewis B., Casavant C. Acquired immune dysfunction in homosexual men: immunologic profiles. Clin Immunol Immunopathol. 1983 Jun;27(3):315–325. doi: 10.1016/0090-1229(83)90084-3. [DOI] [PubMed] [Google Scholar]
  2. Arya S. K., Guo C., Josephs S. F., Wong-Staal F. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science. 1985 Jul 5;229(4708):69–73. doi: 10.1126/science.2990040. [DOI] [PubMed] [Google Scholar]
  3. Barré-Sinoussi F., Chermann J. C., Rey F., Nugeyre M. T., Chamaret S., Gruest J., Dauguet C., Axler-Blin C., Vézinet-Brun F., Rouzioux C. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983 May 20;220(4599):868–871. doi: 10.1126/science.6189183. [DOI] [PubMed] [Google Scholar]
  4. Barré-Sinoussi F., Mathur-Wagh U., Rey F., Brun-Vezinet F., Yancovitz S. R., Rouzioux C., Montagnier L., Mildvan D., Chermann J. C. Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDS. JAMA. 1985 Mar 22;253(12):1737–1739. doi: 10.1001/jama.1985.03350360063019. [DOI] [PubMed] [Google Scholar]
  5. Catovsky D., de Salvo Cardullo L., O'Brien M., Morilla R., Costello C., Galton D., Ganeshaguru K., Hoffbrand V. Cytochemical markers of differentiation in acute leukemia. Cancer Res. 1981 Nov;41(11 Pt 2):4824–4832. [PubMed] [Google Scholar]
  6. Cowan M. J., Ammann A. J. Immunodeficiency syndromes associated with inherited metabolic disorders. Clin Haematol. 1981 Feb;10(1):139–159. [PubMed] [Google Scholar]
  7. Cowan M. J., Fraga M., Andrew J., Laméris-Martin N., Ammann A. J. Purine salvage pathway enzyme activities in human T-, B-, and null lymphocyte populations. Cell Immunol. 1982 Feb;67(1):121–128. doi: 10.1016/0008-8749(82)90204-0. [DOI] [PubMed] [Google Scholar]
  8. Cowan M. J., Fujiwara P., Ammann A. J. Cellular immune defect in selective IgA deficiency using a microculture method for PHA stimulation and limiting dilution. Clin Immunol Immunopathol. 1980 Dec;17(4):595–605. doi: 10.1016/0090-1229(80)90155-5. [DOI] [PubMed] [Google Scholar]
  9. Fauci A. S., Macher A. M., Longo D. L., Lane H. C., Rook A. H., Masur H., Gelmann E. P. NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med. 1984 Jan;100(1):92–106. doi: 10.7326/0003-4819-100-1-92. [DOI] [PubMed] [Google Scholar]
  10. GOLDBERG D. M. SERUM ADENOSINE DEAMINASE IN THE DIFFERENTIAL DIAGNOSIS OF JAUNDICE. Br Med J. 1965 Feb 6;1(5431):353–355. doi: 10.1136/bmj.1.5431.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gallo R. C., Salahuddin S. Z., Popovic M., Shearer G. M., Kaplan M., Haynes B. F., Palker T. J., Redfield R., Oleske J., Safai B. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984 May 4;224(4648):500–503. doi: 10.1126/science.6200936. [DOI] [PubMed] [Google Scholar]
  12. Glader B. E., Backer K., Diamond L. K. Elevated erythrocyte adenosine deaminase activity in congenital hypoplastic anemia. N Engl J Med. 1983 Dec 15;309(24):1486–1490. doi: 10.1056/NEJM198312153092404. [DOI] [PubMed] [Google Scholar]
  13. KOEHLER L. H., BENZ E. J. Serum adenosine deaminase: methodology and clinical applications. Clin Chem. 1962 Apr;8:133–140. [PubMed] [Google Scholar]
  14. Klatzmann D., Barré-Sinoussi F., Nugeyre M. T., Danquet C., Vilmer E., Griscelli C., Brun-Veziret F., Rouzioux C., Gluckman J. C., Chermann J. C. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science. 1984 Jul 6;225(4657):59–63. doi: 10.1126/science.6328660. [DOI] [PubMed] [Google Scholar]
  15. Levy J. A., Hoffman A. D., Kramer S. M., Landis J. A., Shimabukuro J. M., Oshiro L. S. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science. 1984 Aug 24;225(4664):840–842. doi: 10.1126/science.6206563. [DOI] [PubMed] [Google Scholar]
  16. Miwa S., Fujii H., Matsumoto N., Nakatsuji T., Oda S., Asano H., Asano S. A case of red-cell adenosine deaminase overproduction associated with hereditary hemolytic anemia found in Japan. Am J Hematol. 1978;5(2):107–115. doi: 10.1002/ajh.2830050205. [DOI] [PubMed] [Google Scholar]
  17. Murray J. L., Loftin K. C., Munn C. G., Reuben J. M., Mansell P. W., Hersh E. M. Elevated adenosine deaminase and purine nucleoside phosphorylase activity in peripheral blood null lymphocytes from patients with acquired immune deficiency syndrome. Blood. 1985 Jun;65(6):1318–1324. [PubMed] [Google Scholar]
  18. Ownby D. R., Pizzo S., Blackmon L., Gall S. A., Buckley R. H. Severe combined immunodeficiency with leukopenia (reticular dysgenesis) in siblings: immunologic and histopathologic findings. J Pediatr. 1976 Sep;89(3):382–387. doi: 10.1016/s0022-3476(76)80532-x. [DOI] [PubMed] [Google Scholar]
  19. Sodroski J., Patarca R., Rosen C., Wong-Staal F., Haseltine W. Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. Science. 1985 Jul 5;229(4708):74–77. doi: 10.1126/science.2990041. [DOI] [PubMed] [Google Scholar]
  20. Sylwestrowicz T. A., Ma D. D., Murphy P. P., Massaia M., Prentice H. G., Hoffbrand A. V., Greaves M. F. 5'nucleotidase, adenosine deaminase and purine nucleoside phosphorylase activities in acute leukaemia. Leuk Res. 1982;6(4):475–482. doi: 10.1016/0145-2126(82)90004-2. [DOI] [PubMed] [Google Scholar]
  21. Valentine W. N., Paglia D. E., Tartaglia A. P., Gilsanz F. Hereditary hemolytic anemia with increased red cell adenosine deaminase (45- to 70-fold) and decreased adenosine triphosphate. Science. 1977 Feb 25;195(4280):783–785. doi: 10.1126/science.836588. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES